Janet Meiklejohn Joins Renaissance BioScience Corp. as Chief Financial Officer
Vancouver, BC, June 21, 2018--(T-Net)--Renaissance BioScience Corp., a leading global yeast technology company, announced today the appointment of Janet Meiklejohn as its Chief Financial Officer (CFO).
Ms. Meiklejohn brings to the position extensive and wide-ranging experience at the executive level in capital markets, finance and business development.
Ms. Meiklejohn will replace company co-founder Maurice Boucher, who has held the CFO position since the company's inception. Mr. Boucher will shift his priorities within Renaissance to concentrate on and expand his duties as Executive Chairman.
Ms. Meiklejohn brings more than 20 years of capital markets experience at a number of financial institutions, including Macquarie Canada, National Bank and Desjardins Securities advising institutional investors on their portfolio investments and raising capital for companies in both the public and private markets.
Most recently, she was interim CFO and VP Corporate Development at Qu Biologics, a private biotech company. While serving in this role, Ms. Meiklejohn managed all aspects of financial planning and analysis, and worked closely with the company's executive team and board of directors to help guide strategy, organizational structure, strategic partnerships and other matters.
Ms. Meiklejohn began her career as a CPA at Ernst & Young. She holds a bachelor's degree in Business Administration from the Paul Hill School of Business at the University of Regina, and an MBA from the Richard Ivey School of Business at the University of Western Ontario.
"We are excited to welcome Janet to Renaissance as our new CFO as we make the transition to a publicly listed company," said Dr. John Husnik, CEO of Renaissance. "Janet brings extensive financial, operational and strategic experience. This, combined with her experience working with high-growth companies in mergers and acquisitions, capital structuring and investor relations, will be a huge asset to Renaissance as we enter our next phase of growth, expanding our technology platform and partnerships into other industries.
He added, "I wish to think co-Founder Maurice Boucher for his past five years of taking responsibility for the CFO role. As co-founders, we both recognize the need for Renaissance to continue to add to its executive team skills and experience as the company enters its next phase of development and growth."
"I am very happy to be joining Renaissance at such an exciting time. Over the past five years, the company has transformed and grown its technology platform to include commercial success with multiple product categories in the food and beverage markets. I look forward to building on this strong scientific technology platform and helping the team to establish further high-profile partnerships, and expand commercialization in other industries in addition to our current food and beverage industry commercial contracts," commented Janet Meiklejohn.
About Renaissance BioScience Corp.
Renaissance BioScience Corp., based in Vancouver, Canada, is a privately held applied life sciences company that develops novel, yeast-based, patent-protected technologies for the global food, beverage, nutrition, biofuel and pharmaceutical industries. The wholly owned commercial subsidiaries of Renaissance BioScience Corp. include Renaissance Yeast Inc., which commercializes hydrogen sulfide-preventing wine yeast; Renaissance Ingredients Inc., which commercializes acrylamide-reducing yeast; and Bright Brewers Yeast Inc., which commercializes beer yeast technologies. Detailed information about the Renaissance group of companies can be accessed at www.renaissancebioscience.com.
Campbell & Company Strategies Inc.
Communications and Public Relations
01 604 888-5267
tech@ccom-pr.com
Renaissance BioScience Corp.
Vancouver (Biotech/Life Sciences)
10-19 Employees In BC (10-19 Employees Total)
Renaissance BioScience is a privately held life sciences company based in Vancouver, BC, that develops yeast-based platform technologies that solve important safety and quality problems in the food, beverage, biofuel, and pharmaceutical industries.
1 - 3 of 6 Results New Search
Renaissance BioScience files PCT Patent Application for RNA Bioactive Molecule Production and Delivery Technology Platform
Renaissance Bioscience Partners With Mitacs for $1.44 Million Project to Advance Next-Generation Yeast Development Platform
Want More Renaissance BioScience Corp. News? 1
Vancouver, BC (Biotech/Life Sciences)